BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 16536756)

  • 1. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
    Beisland C; Talleraas O; Bakke A; Norstein J
    BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple primary malignancies in renal cell carcinoma.
    Rabbani F; Grimaldi G; Russo P
    J Urol; 1998 Oct; 160(4):1255-9. PubMed ID: 9751330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
    Barocas DA; Rabbani F; Scherr DS; Vaughan ED
    BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence?
    Tihan T; Filippa DA
    Cancer; 1996 Jun; 77(11):2325-31. PubMed ID: 8635103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between malignant melanoma and noncutaneous malignancies.
    Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
    Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
    Czene K; Hemminki K
    J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of bilateral renal cell cancer.
    Wiklund F; Tretli S; Choueiri TK; Signoretti S; Fall K; Adami HO
    J Clin Oncol; 2009 Aug; 27(23):3737-41. PubMed ID: 19597028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies.
    Brock MV; Alberg AJ; Hooker CM; Kammer AL; Xu L; Roig CM; Yang SC
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1119-25. PubMed ID: 15052211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
    Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous colorectal and renal carcinomas. Is it a definite clinical entity?
    Capra F; Scintu F; Zorcolo L; Marongiu L; Casula G
    Chir Ital; 2003; 55(6):903-6. PubMed ID: 14725233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resected synchronous primary malignant lung tumors: a population-based study.
    Rostad H; Strand TE; Naalsund A; Norstein J
    Ann Thorac Surg; 2008 Jan; 85(1):204-9. PubMed ID: 18154811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
    Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second primary malignant tumors in patients with primary renal cell carcinoma].
    Turkić M; Znaor A; Novosel I; Reljić A; Belicza M; Kruslin B
    Acta Med Croatica; 2005; 59(2):91-5. PubMed ID: 15909881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment.
    Becker F; Siemer S; Tzavaras A; Suttmann H; Stoeckle M
    Urology; 2008 Aug; 72(2):349-53. PubMed ID: 18485459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Aron M; Nguyen MM; Stein RJ; Gill IS
    Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.